ALDH1A1 and lip and oral cavity carcinoma: The analysis of survival probabilities for the 63 patients with oral cancer in 5 years showed a lower probability of overall survival, with a significant difference, for patients with strong immunoexpression of ALDH1 (p = 0.040; Table 4 and Figure 2).